Pessary Industry
The global pessary market size is expected to reach USD 590.5 million by 2030, registering a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increase in the demand for pessaries has been witnessed in recent years as compared to the surgeries performed for pelvic organ prolapse. Easy and convenient application has largely favored the growing usage of pessaries among patients.
According to the U.S. Census Bureau, the number of women aged 65 years and above in America would double by 2030 to reach over 40 million. Vaginal pessaries have a high success rate and minimal complication rate for the treatment of both incontinence and prolapse. When successfully fitted, they are associated with high patient satisfaction.
Sedentary lifestyles and lifestyle-associated diseases are also expected to contribute to market growth. The increasing prevalence of diseases such as urinary inconsistency, pelvic organ prolapse and the rising number of geriatric population is fueling the demand for vaginal pessaries.
The market for vaginal pessary is competitive. The most notable participants in the market are CooperSurgical, Biotique America, and MedGyn. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, CooperSurgical, based in the United States, invented the Milex Pessary Fitting Kit. The kit is designed for physicians and doctors who can use it to determine the exact size of the patient and prescribe the pessary accordingly. The introduction of these detailed analyses marks a significant shift in focus in the field of female healthcare around the world, which is propelling the market forward.
Gather more insights about the market drivers, restrains and growth of the Global Pessary market
Pessary Market Segments Highlights:
- In terms of type, the ring pessary segment dominated the market in 2024, since the device is easy to insert and remove
- The hospitals segment held the largest revenue share in 2024, as they are the primary point of care for treatment, furthermore, hospitals are known to offer superior care to their patients, and treatment at these centers are generally reimbursed, which drives adoption
- The clinic segment is predicted to witness the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in clinics
- North America dominated the market in 2024 due to the increasing R&D spending, rising demand for medication development, strong governmental efforts, and current projects
- Asia Pacific is expected to register the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of pelvic organ prolapse
Pessary Market Report Segmentation
Grand View Research has segmented the global pessary market based on type, end use, region:
Pessary Type Outlook (Revenue, USD Million, 2018 - 2030)
- Gellhorn
- Ring
- Donut
- Others
Pessary End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Clinics
- Ambulatory Surgery Centers
Pessary Region Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Key Pessary Company Insights
- CooperSurgical Inc.
- Bliss GVS Pharma Limited
- MedGyn Products, Inc.
- Panpac Medical Corp.
- Bioteque America Inc.
- Personal Medical Corp.
- Arabin GmbH & Co. KG
- INTEGRA LIFESCIENCES
Order a free sample PDF of the Pessary Market Intelligence Study, published by Grand View Research.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian